Future Positive Capital

Summary

In 2017 was created Future Positive Capital, which is appeared as VC. The leading representative office of defined VC is situated in the Paris. The venture was found in Europe in France.

The real fund results show that this VC is 30 percentage points more often commits exit comparing to other companies. The usual things for fund are deals in the range of 5 - 10 millions dollars. The top activity for fund was in 2018. The fund is constantly included in less than 2 investment rounds annually.

This organization was formed by Alexandre Terrien, Michael Rosen, Sofia Hmich. Besides them, we counted 3 critical employees of this fund in our database.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Future Positive Capital, startups are often financed by Emertec Gestion, Demeter Partners, VisVires New Protein. The meaningful sponsors for the fund in investment in the same round are Astanor Ventures, iNovia Capital, VisVires New Protein. In the next rounds fund is usually obtained by Astanor Ventures, VisVires New Protein, Talis Capital.

Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Among the most successful fund investment fields, there are Local Business, Agriculture. Among the most popular portfolio startups of the fund, we may highlight Ynsect, Cervest, Cervest. The fund has no specific favorite in a number of founders of portfolio startups. In case when startup counts 2 or 5+ of the founder, the chance for it to get the investment is meager.